Skip to content

Clinical study on the prevention of adverse reactions after aesthetic treatment with sunscreen containing physical and chemical sunscreen agents and antioxidant combinations

Clinical study on the prevention of adverse reactions after aesthetic treatment with sunscreen containing physical and chemical sunscreen agents and antioxidant combinations

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129613
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-06
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-inflammatory pigmentation

Interventions

Control side:Only physical sun protection
Test side:Physical sun protection+Test product

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Healthy male or female subjects aged 20–45 years; 2.Have completed mesotherapy (skin booster) treatment; 3.Skin condition on the left and right sides of the face is essentially symmetrical; 4.Agree not to use other skincare products, medications, or undergo other aesthetic procedures that may affect the study outcomes during the trial period; 5.Able to comply with the trial requirements; 6.Provide informed consent and sign the written informed consent form;

Exclusion criteria

Exclusion criteria: 1.History of allergy to hyaluronic acid; 2.Currently suffering from skin diseases or severe allergies, or with a history of treatments that may affect skin healing; 3.Having skin cancer or suspected skin cancer; 4.Received non-absorbable filler injections, laser therapy, or facial implants within the past year; 5.Suffering from severe systemic diseases, such as heart disease or poorly controlled diabetes; 6.Women who are pregnant, breastfeeding, or planning to become pregnant during the treatment period; 7.History of keloid formation or abnormal wound healing; 8.Skin hypersensitivity; 9.Unable to avoid prolonged and intense sun exposure in the near future (e.g., long-term outdoor workers); 10.Suffering from psychiatric disorders or other conditions that may affect treatment compliance; 11.Deemed unsuitable for participation in the trial based on clinical evaluation;

Design outcomes

Primary

MeasureTime frame
Transepidermal Water Loss;Skin redness degree (a value);

Secondary

MeasureTime frame
Safety assessment;

Countries

China

Contacts

Public ContactWang Xi

West China Hospital of Sichuan University

xierwang@126.com+86 28 85422075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026